Autoimmune Medical News by Date | |
| February 2009 | |
| Autoimmune Thyroiditis and Rheumatoid Arthritis RA) : Is There Really an Association? There was no correlation between thyroid disease and rheumatoid factor, antinuclear antibodies, disease modifying drugs use, corticosteroid use, or RA disease activity. In conclusion, no association could be demonstrated between thyroid disease and RA. F.T. Goncalvez, MD. The Endocrinologist. January/February 2009. (Also see: Rheumatoid Arthritis and Thyroid Disease) | |
| Impact of smoking as a risk factor for developing rheumatoid arthritis (RA): A meta-analysis of observational studies. Smoking is a risk factor for RA for and is especially strongly associated with RA for RF+ male and both male and female heavy smokers. D. Sugiyama. Ann Rheum Dis. 27 January 2009. (Alse see: Rheumatoid Arthritis) | |
| High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis (RA). High levels of disease activity and disability during the first 2 years after RA diagnosis, smoking and rheumatoid factor (RF) predict the development of severe extra-articular RA. B.M. Nyhall-Wahlin. Rheumatology Advance Access. February 12, 2009. (Also see: Rheumatoid Arthritis) | |
| Spatial-temporal parameters of gait in women with fibromyalgia (FM). Gait parameters of women affected by FM were severely impaired when compared to those of healthy women. Different factors such as lack of physical activity, bradikinesia, overweight, fatigue, and pain together with a lower isometric force in the legs can be responsible for the alterations in gait and poorer life quality of women with FM. (SpringerLink) J. Jimenez. Clinical Rheumatology. January 24, 2009. (Also see: Fibromyalgia) | |
| Fibromyalgia (FM) is associated with impaired balance and falls. FM is associated with balance problems and increased fall frequency. These results suggest that FM may affect peripheral and/or central mechanisms of postural control. (PubMed) K.D. Jones. J Clin Rheumatol. February 2009. (Also see: Fibromyalgia) | |
| Fibromyalgia pain may cause memory blips. People with the disease may have disruption in their memory because of the pain. Those patients that were on narcotics or opiates had much better memories. Q. Phillips. PhysOrg.com. 12/19/08. (Also see: Fibromyalgia) | |
| Association of killer cell immunoglobulin -like receptors (KIRs) with primary Sjögren's syndrome (SS). Autologous KIR–ligand interaction may be a contributory factor to predisposition for SS. D. Lowe. Rheumatology. January 30, 2009. (Also see: Sjögren's and Killer Cells) | |
| Prednisone, Lupus Activity, and Permanent Organ Damage. Our results suggest that low doses of prednisone do not result in a substantially increased risk of irreversible organ damage. M. Thamer. J. Rheum. February 4, 2009. (Also see: Lupus and Prednisone) | |
| Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus (SLE): a systematic review. Given the broad spectrum of beneficial effects and the safety profile, hydroxychloroquine (HCQ) should be given to most patients with SLE during the whole course of the disease, irrespective of its severity, and be continued during pregnancy. G Ruiz-Irastorza. Annals of Rheumatic Diseases. 22 December 2008. (Also see: Lupus) | |
| The use of fish oil in the community: results of a population-based study. Fish oil has been demonstrated to have symptomatic benefits and improve disease activity in Rheumatoid Arthritis. C. Hill. Rheumatology. January 27, 2009. (Also see: Rheumatoid Arthritis and Alternative Therapies) | |
| Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. The findings in this study that improvement of health is possible to achieve should encourage further studies with interventions with probiotics in patients with chronic fatigue syndrome (CFS). The findings suggest that improvement of health is possible to achieve with interventions with probiotics in patients with CFS. A. Sullivan. Nutrition Journal. January 26, 2009. (Also see: CFS Treatments and Probiotics) | |
| Current Therapies for Lupus Nephritis in an Ethnically Heterogeneous Cohort. After controlling for the fact that less severe nephritis is preferentially treated with mycophenolate mofetil (MMF), we found overall that response to MMF was superior to intravenous cyclophosphamide. T. Rivera. J Rheumatol. Dec 1 2008. (Also see: Lupus and Cellcept) |
|
||||||||||||
| Go to Autoimmune News: January 2009 | ||||||||||||
|
||||||||||||